Systemic sclerosis: CT-derived evaluation of interstitial lung disease and pulmonary vasculopathy for assessment of progression of disease. Research protocol for extended volume HRCT-thorax in patients with systemic sclerosis participating in a 2 *day multidisciplinary team care program of the department of Rheumatology and Pulmonology
Recruiting
- Conditions
- long fibrosis100038161001076110024967
- Registration Number
- NL-OMON44504
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Diagnosis of systemic sclerosis according to ACR/EULAR 2013 criteria or suspected / confirmed fibrotic lung disease
2. Age * 18 years
3. First consultation at Zorgpad Sclerodermie LUMC or the dedicated ILD outpatient clinic and high risk profile* and/or low DLCO/ and/or low FVC which indicates a standard HRCT scan
4. Life expectancy > 6 months
5. Able and willing to undergo annual follow-up for 3 consecutive years
6. Written informed consent
Exclusion Criteria
1. Inability to perform pulmonary function testing
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>zie nederlandse samenvatting</p><br>
- Secondary Outcome Measures
Name Time Method <p>zie nederlandse samenvatting</p><br>